US Patent Issued to H. Lundbeck on Aug. 12 for "Treatment of most bothersome symptom (MBS) associated with migraine using anti-CGRP antibodies" (American, Irish Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,837, issued on Aug. 12, was assigned to H. Lundbeck A/S (Valby, Denmark).

"Treatment of most bothersome symptom (MBS) associated with migraine using anti-CGRP antibodies" was invented by Roger K. Cady (Bothell, Wash.), Jeffrey T. L. Smith (Dublin) and Joseph Hirman (Bothell, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treatment of most bothersome symptom (MBS) associated with migraine are provided. Exemplary methods provide improvement in MBS associated with migraine within 1 month of administration og anti-CGRP antibodies of the invention. Also provided are methods for improvement of patient impression of change (PGIC) associat...